IRIS
PONTREMOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 26.798
AS - Asia 46
SA - Sud America 30
NA - Nord America 4
Totale 26.878
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 26.798
CN - Cina 31
BR - Brasile 24
SG - Singapore 9
VN - Vietnam 5
US - Stati Uniti d'America 4
AR - Argentina 3
CO - Colombia 1
IQ - Iraq 1
PY - Paraguay 1
VE - Venezuela 1
Totale 26.878
Salva come PNG Salva come JPEG
Città #
Genova 16.085
Genoa 6.791
Rapallo 2.117
Vado Ligure 1.761
Bordighera 39
Beijing 14
Singapore 9
Rome 3
Ashburn 2
Brasília 2
Ho Chi Minh City 2
Naples 2
Santo André 2
Abreu e Lima 1
As Samawah 1
Barquisimeto 1
Bắc Ninh 1
Cabo Frio 1
Cocoa 1
Cotia 1
Da Nang 1
Embu das Artes 1
Fortaleza 1
Itanhaém 1
Itaquaquecetuba 1
Itumbiara 1
Jacareí 1
Lomas de Zamora 1
Maceió 1
Mariano Moreno 1
New York 1
Osasco 1
Paulo Afonso 1
Paulo Ramos 1
Phủ Lý 1
Pindorama 1
Recife 1
Rio Claro 1
San Justo 1
Santiago de Cali 1
São João Nepomuceno 1
São Paulo 1
São Sebastião 1
Tupã 1
Totale 26.860
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 258
Left ventricular dilatation and subclinical renal damage in primary hypertension 215
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 180
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 179
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 178
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 176
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 171
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 168
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 167
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 167
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 167
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 166
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 161
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 156
Cardiovascular and renal effects of hyperuricaemia and gout. 155
C-reactive protein and target organ damage in untreated patients with primary hypertension. 155
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 153
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 152
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 151
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 150
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 150
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 150
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 149
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 148
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 148
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 148
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 148
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 147
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 146
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 146
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 146
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 145
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 145
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 145
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 143
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 143
Amino acid imbalance in patients with chronic renal failure. 141
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 140
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 139
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 139
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 139
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 138
Blood pressure variability and multiple organ damage in primary hypertension 137
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 137
Use of nifedipine in the treatment of hypertension. 136
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 136
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 136
Creatinine clearance and early signs of target organ damage in primary hypertension 136
Microalbuminuria in primary hypertension: a guide to optimal patient management? 136
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 136
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 136
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 135
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 134
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 134
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 134
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 134
Sub-clinical organ damage in hypertension and obesity 133
Mild renal dysfunction and renal vascular resistance in primary hypertension 132
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 132
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 131
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 130
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 130
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 130
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 130
Hyperuricemia and renal risk 130
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 129
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 129
Highlights from International Congress 129
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 129
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 129
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 129
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 128
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 128
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 128
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 127
Renal ammoniagenesis in man with chronic potassium depletion. 127
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 126
Albuminuria: The kidney message on cardiovascular health 126
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 126
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 126
Renal and cardiac abnormalities in primary hypertension 126
Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy 126
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 126
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 125
Overall health assessment: a renal perspective. 125
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 124
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 124
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 124
Chronic kidney disease and albuminuria in arterial hypertension. 124
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 124
Diffusion-weighted MRI sequences (DW-MRI) of the kidney: normal findings, influence of hydration state and repeatibility of results 123
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 122
Hypernatremia associated with severe rhabdomyolysis. 122
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 121
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 121
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 121
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 121
RAAS Inhibition and Renal Protection 120
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 120
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 120
Totale 14.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.950
article - articoli 91.174
book - libri 0
conference - conferenze 0
curatela - curatele 470
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 306
Totale 183.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.698 0 0 0 169 109 169 209 226 188 260 157 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.596 263 155 24 272 382 467 47 209 444 62 212 59
2023/20241.396 71 198 36 145 133 266 72 83 82 14 93 203
2024/20254.503 100 343 148 297 598 453 428 702 228 227 459 520
2025/20262.433 888 353 629 563 0 0 0 0 0 0 0 0
Totale 27.486